All Type of News
Sam-A to patent a composite process of Carmodix suspension tablet.
Sam-A Pharm. Co. announced on Sept. 21 that the manufacturing process and the composite of Carmodix suspension tablet, a combined penicillin antibiotic of AMX/CLA made patent registration (Pat. Reg. No. 0515311) in Ko...
70% of advanced prostate cancer diagnosed at hospital visits.
41% of the early prostate cancer patients found their disease at their regular health checks while 70% of the advanced (4th stage) prostate cancer patients at their hospital visits on account of their urination diffic...
4 medical groups to watch illegal practices.
A medical group has formed a supervisory squad against any illegal medical practices committed at the pharmacy, running from coming Oct.
4 medical groups, the Korea Medical Association, the Korean Dental Associatio...
Rampant illegal and unfair practices in pharmacies.
Illegal and unfair business practices at pharmacy circles surged with a rampant feature, and the KPA's slogan of "A proud pharmacist, a faithful pharmacist model" seems to echo back with a vacant word.
According...
Company withdrawal of drug registration on the rise.
As a result of implementing the graded assessment of the KGMP plants, a rapid increase of the self withdrawal of drug registration showed almost 5 times more this year than the previous year, indicating that the drug ...
3 in 10 Koreans are obese.
Rep. Lee Ki-woo of Woori Party said that 3 in 10 Koreans were overweighted according to a survey on the NHI insured population aged over 40 years or older in 2004, which was 30.7% increases over the previous year of 2...
Over 50% of Korean adults still smoke.
After the price increase of all tobaccos in Dec. last year, number of smoker populations showed ever declining trend but still kept at over 50%, a survey unveiled.
The Korean adult smokers showed 57.8% in Sept. las...
Hwail Inc. to get 21 DMF certified products.
Hwail Pharmaceutical company announced on Sept. 20 that 21 bulk drugs have been DMF certified by the KFDA since its enforcement from Sept. 1 this year.
The company said that the total production and import value of...
KFDA approved Yuhan's anti-peptic drug Revanex tab.
Yuhan said that as of Sept. 15 the new drug named Revanex (Revaprazan) has been completely registered to the KFDA as an anti-duodenal ulcer drug, which will be of No. 9 of Korean new drug.
Revanex has been develope...
KFDA Drug Safety Bureau to reshuffle.
The Drug Safety Bureau of KFDA has been reshuffled.
As of Sept. 15, Mr. Chang Young-wook, the 5th grade officer, finished his mission to work at the Board of Audit and Inspection of Korea and return to the Drug Saf...
